Detalles de la búsqueda
1.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816326
2.
The CoV-2 outbreak: how hematologists could help to fight Covid-19.
Pharmacol Res
; 157: 104866, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387301
3.
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.
Cancer Cell Int
; 19: 83, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992690
4.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325190
5.
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
Front Oncol
; 10: 1428, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014780
6.
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.
Cancers (Basel)
; 12(7)2020 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629801
7.
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
Front Oncol
; 9: 528, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293969
8.
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
Front Oncol
; 9: 532, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293972
9.
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Front Oncol
; 8: 555, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30574454
10.
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Oncotarget
; 8(45): 79188-79200, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108298
11.
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
Front Pharmacol
; 8: 413, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28706485
12.
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
Cancer Chemother Pharmacol
; 79(4): 767-773, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28289867
13.
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
Oncotarget
; 8(50): 88021-88033, 2017 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29152138
14.
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.
Front Pharmacol
; 7: 363, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27790140
15.
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.
Hemasphere
; 5(10): e639, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34514343
16.
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.
Br J Haematol
; 149(3): 451-4, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20085581
17.
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation.
Clin Hematol Int
; 2(3): 129-131, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595453
18.
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Clin Cancer Res
; 20(24): 6398-405, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316810
19.
Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.
J Clin Exp Hematop
; 53(1): 29-36, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801131
Resultados
1 -
19
de 19
1
Próxima >
>>